Abranilla, Baby Girl .
HRN: 26-63-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/12/2025
03/10/2025
IVTT
110mg
Q12h
PCAP D
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes